Extrauterine vulvar smooth muscle tumor of uncertain malignant potential in a young woman: a rare case report

Abstract Background Smooth muscle tumors of uncertain malignant potential (STUMP) of the vulva are exceedingly rare mesenchymal neoplasms with no established management guidelines. Their morphologic overlap with rhabdomyosarcoma and leiomyosarcoma makes initial biopsy interpretation prone to error, and the adjuvant strategy after resection remains undefined. Case presentation A 20-year-old nulligravid woman presented with a 15 × 15 × 5 cm lobulated, friable, actively bleeding vulvar–suprapubic mass and life-threatening anemia (hemoglobin 2 g/dL), following two prior excisions at outside institutions with conflicting pathology reports — embryonal (botryoid-type) rhabdomyosarcoma on first biopsy, STUMP on central review, then rhabdomyosarcoma again on a third biopsy. Immunohistochemistry at our institution (Myogenin−, MyoD1−, Desmin−, SMA+, Vimentin−, Ki-67 < 4%, with necrosis) excluded rhabdomyosarcoma and supported STUMP. After stabilisation with packed red cell transfusion, the patient underwent radical local excision with negative margins, followed by single-stage reconstruction with split-thickness skin graft (STSG). Given the shallow wound bed, STSG was preferred over flap reconstruction. Because final margins were free, no adjuvant therapy was administered, and the patient was placed on structured surveillance. Conclusion This case illustrates three practical lessons in the management of vulvar STUMP. First, small-biopsy diagnosis of genital-tract spindle cell tumors is unreliable and should prompt centralized pathology review with a lineage-resolving immunohistochemistry panel before definitive treatment. Second, the choice between skin graft and flap reconstruction is guided primarily by wound-bed depth and vascularity rather than tumor biology. Third, in vulvar STUMP resected to negative margins, observation may be considered given the absence of evidence supporting adjuvant chemotherapy or radiotherapy; however, with only one month of follow-up, long-term oncological outcome remains unknown.

Authors

Institutions

Publication Details

Journal
Discover Oncology
Published
2026-11-15
DOI
https://doi.org/10.1007/s12672-026-06256-7
Primary Topic
Urologic and reproductive health conditions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Extrauterine vulvar smooth muscle tumor of uncertain malignant potential in a young woman: a rare case report

Roni Yunarto, Nicholas Adrianto, Candra Novi Ricardo Sibarani, Putri Nadya Syahidah
Discover Oncology
Urologic and reproductive health conditions
article

Extrauterine vulvar smooth muscle tumor of uncertain malignant potential in a young woman: a rare case report

Roni Yunarto, Nicholas Adrianto, Candra Novi Ricardo Sibarani, Putri Nadya Syahidah
article en

Abstract

Abstract Background Smooth muscle tumors of uncertain malignant potential (STUMP) of the vulva are exceedingly rare mesenchymal neoplasms with no established management guidelines. Their morphologic overlap with rhabdomyosarcoma and leiomyosarcoma makes initial biopsy interpretation prone to error, and the adjuvant strategy after resection remains undefined. Case presentation A 20-year-old nulligravid woman presented with a 15 × 15 × 5 cm lobulated, friable, actively bleeding vulvar–suprapubic mass and life-threatening anemia (hemoglobin 2 g/dL), following two prior excisions at outside institutions with conflicting pathology reports — embryonal (botryoid-type) rhabdomyosarcoma on first biopsy, STUMP on central review, then rhabdomyosarcoma again on a third biopsy. Immunohistochemistry at our institution (Myogenin−, MyoD1−, Desmin−, SMA+, Vimentin−, Ki-67 < 4%, with necrosis) excluded rhabdomyosarcoma and supported STUMP. After stabilisation with packed red cell transfusion, the patient underwent radical local excision with negative margins, followed by single-stage reconstruction with split-thickness skin graft (STSG). Given the shallow wound bed, STSG was preferred over flap reconstruction. Because final margins were free, no adjuvant therapy was administered, and the patient was placed on structured surveillance. Conclusion This case illustrates three practical lessons in the management of vulvar STUMP. First, small-biopsy diagnosis of genital-tract spindle cell tumors is unreliable and should prompt centralized pathology review with a lineage-resolving immunohistochemistry panel before definitive treatment. Second, the choice between skin graft and flap reconstruction is guided primarily by wound-bed depth and vascularity rather than tumor biology. Third, in vulvar STUMP resected to negative margins, observation may be considered given the absence of evidence supporting adjuvant chemotherapy or radiotherapy; however, with only one month of follow-up, long-term oncological outcome remains unknown.

Discover Oncology
Atma Jaya Catholic University of Indonesia (ID), Dr. Hasan Sadikin General Hospital (ID), Padjadjaran University (ID)
Urologic and reproductive health conditions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon